NDC 66657-301-01 - GANITE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66657-301
- Requested NDC
- 66657-301-01
- Package NDCs from labels
- 66657-301-01, 66657-301-05
- Manufacturer
- Genta Incorporated | Cangene BioPharma Inc
- Effective date
- 2012-03-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GANITE - Genta Incorporated | Cangene BioPharma Inc | Genta Incorporated | Cangene BioPharma Inc | 2012-03-19 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66657-301-05 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c125-f6ea-e053-dbdaa90aa703 | Ganite® (gallium nitrate injection) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66657-301-01 | GANITE | 20 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION, CONCENTRATE | 20 | 4 | |
| 66657-301-05 | GANITE | 5 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 5 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66657-301-01 | ML - Milliliter | 66657-301 | c178db83-059e-48b3-b6a5-a425d6ce645a | 1 | 2012-07-24 |
| 66657-301-05 | ML - Milliliter | 66657-301 | 18a5a3ff-58df-4bf1-aa0b-528d13799194 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GALLIUM NITRATE | ACTIVE INGREDIENT | VRA0C6810N | GANITE (GALLIUM NITRATE) INJECTION, SOLUTION, CONCENTRATE [GENTA INCORPORATED] | 4 | |
| Gallium cation | ACTIVE MOIETY | F7K5MP217W | GANITE (GALLIUM NITRATE) INJECTION, SOLUTION, CONCENTRATE [GENTA INCORPORATED] | 4 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | GANITE (GALLIUM NITRATE) INJECTION, SOLUTION, CONCENTRATE [GENTA INCORPORATED] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 448a1dc5-7a98-4b2f-82af-4b92de05cfc3 | 2019-11-18 | B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 051f7347-5a76-4664-8fe2-e61b3dfcb0e4 | 2014-08-27 | B22547B95K | |
| 91011848-9bcb-4ccc-83b1-a53c4d8e219b | 8bc2ddf8-d695-46b3-bf76-9f85ce6027e3 | 2012-03-19 | Boxed warning, Warnings, Adverse reactions | 91011848-9bcb-4ccc-83b1-a53c4d8e219b 8bc2ddf8-d695-46b3-bf76-9f85ce6027e3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.